Clinical Trial Update: Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis [Phase 1]

View source ↗

Summary

Phase 1 trial of sorafenib for locally advanced or metastatic liver cancer in patients with cirrhosis has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Liver Cancer | Phase 1 | Status: TERMINATED